Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials - The Lancet Respiratory Medicine
Jeremy Howick - 'Blinding' or 'masking' in clinical trials is usually but not always a good thing. See the chapter from my book 'Questioning Double Blinding as a Universal Methodological Virtue of
Evaluating the Effects of Therapy Masking
Data masking vs De-identification vs Anonymization
Randomization and Blinding (Masking)
Blinding/Masking in Clinical Trials - YouTube
Blinding/Masking in Clinical Trials - YouTube
PDF) Bias control in clinical trials: masking or blinding
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ
Matt Sydes on Twitter: "We have set out new guidance to help protect blinding in “blinded” #ClinicalTrials. This relates to Electronic Health Records. Our (short!) letter in Clinical Trials is here: doi:10.1177/17407745211069985 #
What Is Blinding (Or Masking), and Why Is It So Important? – Heidi R. Gardner
Lecture8
Blinding/Masking in Clinical Trials - YouTube
Blinding in clinical trilas
Descriptors in the study design/masking field in the analysed... | Download Scientific Diagram
Conceptos generales en bioestadística y epidemiología clínica: estudios experimentales con diseño de ensayo clínico aleatorizado - Medwave
Jacob S. Aday, Ph.D. on Twitter: "This functional unmasking coupled with the exceptional expectations engendered by media and researchers about the drugs' therapeutic benefits make it virtually impossible to maintain the independence
Design and Interpretation of Clinical Trials | Coursera
Descriptors of blinding/masking in clinical trial registries other than... | Download Scientific Diagram
What Is Blinding (Or Masking), and Why Is It So Important? – Heidi R. Gardner
Clinical impact and quality of randomized controlled trials involving interventions evaluating artificial intelligence prediction tools: a systematic review | npj Digital Medicine
Clinical Trial Glossary
Obstacles to the reuse of study metadata in ClinicalTrials.gov | Scientific Data